Asbestos and cancer

Asbestos is a group of naturally occurring mineral fibers that, when inhaled, cause cancer decades after initial exposure. The most directly linked cancer is malignant mesothelioma, an aggressive cancer of the lining of the lungs (pleura), abdomen (peritoneum), or heart (pericardium). Asbestos is also a recognized cause of lung cancer and has been associated with cancers of the larynx and ovary.

Asbestos fibers, particularly long, thin varieties such as crocidolite (blue asbestos) and amosite (brown asbestos), are biopersistent: once inhaled, they lodge in lung and pleural tissue and cannot be cleared by normal cellular defenses. Embedded fibers generate reactive oxygen species continuously, causing ongoing oxidative DNA damage and chronic inflammation. They also physically disrupt chromosome segregation during cell division, producing chromosomal instability. In pleural mesothelial cells, decades of fiber-induced injury and repair lead to the progressive loss of tumor suppressor genes, including BAP1, CDKN2A, and NF2, driving malignant transformation. The typical latency between first asbestos exposure and mesothelioma diagnosis is 30 to 50 years, which is why new cases continue to emerge long after regulatory bans. Peritoneal mesothelioma likely arises from fibers that migrate from the lung via the lymphatic system. Even low-level environmental exposure, for example among household members of asbestos workers who carried fibers home on their clothing, carries measurable risk.

A Global Burden of Disease 2023 analysis found that cancer attributable to occupational asbestos exposure caused substantial ongoing mortality and disability-adjusted life years (DALYs) across the Americas from 1990 to 2023, with the burden differing significantly by country based on historical asbestos use patterns (PMID 42005088). In Italy, where asbestos was banned in 1992, modeling studies show that mesothelioma mortality has begun to decline in younger male cohorts, but cases continue to accumulate due to the long disease latency, and the peak burden in some cohorts may not yet have been reached (PMID 41895818). Analysis of Spain's pleural cancer mortality from 1984 to 2023, following a national asbestos ban in 2002, showed declining mortality in younger men but persistently high rates in older cohorts exposed before the ban (PMID 41862332). A population-based study in central Italy found that pleural mesothelioma continued to have poor outcomes, with median survival of roughly 15 to 17 months in recent cohorts, and incidence had not clearly declined 30 years after the national ban (PMID 41851683). A study from Colombia described clinical characteristics of pleural mesothelioma in Latin America, highlighting that the global burden is shifting toward lower-income countries where asbestos use persisted or continues (PMID 42062618). A nationwide Japanese survey estimated the proportion of lung cancer patients whose disease was attributable to asbestos exposure under national compensation criteria, aiming to inform adequate coverage for affected workers (PMID 41860806). A study of former asbestos miners in South Africa found elevated all-cause mortality consistent with the well-established health effects of prolonged occupational asbestos exposure (PMID 41882990). A systematic review and meta-analysis examining whether asbestos-free talc is associated with respiratory cancers found the evidence inconclusive for talc alone, while noting that asbestos-contaminated talc carries a clear mesothelioma risk (PMID 41967769). Research on young mesothelioma patients (age 50 or younger) found that this group had more frequent BAP1 mutations and distinct genomic characteristics compared to older patients, suggesting a potentially different biological disease course in this subgroup (PMID 41849731). Case reports have documented mesothelioma in patients with no identifiable asbestos exposure, including a person with Familial Mediterranean Fever, in whom chronic serosal inflammation may have contributed to mesothelial transformation (PMID 41953408).

Historically, asbestos-related cancers have predominantly affected men who worked in heavy-exposure industries: shipbuilding, construction, insulation installation, asbestos mining, and asbestos manufacturing. Women have been affected through para-occupational and domestic exposure. The long latency means that current cases in high-income countries largely reflect exposures from the mid-20th century, while cases in lower-income countries where asbestos use persisted later are still accumulating. Young mesothelioma patients and those without identifiable asbestos exposure represent a growing proportion of cases, with genetic predisposition, particularly germline BAP1 mutations, potentially playing a larger role in this group.

The causal relationship between asbestos and mesothelioma is one of the most clearly established in occupational medicine, supported by epidemiological studies spanning more than 60 years, mechanistic research, and natural policy experiments in countries that have banned asbestos and subsequently observed declining incidence in younger cohorts. The evidence is sufficient to establish causality without scientific debate. The shift of the mesothelioma burden toward lower-income countries reflects historical patterns of industrial regulation and remains a serious global concern. Current research focuses on improving early diagnosis, identifying non-asbestos contributing factors, and developing effective treatments for a disease that remains difficult to manage.

Asbestos is a well-characterized occupational carcinogen with no established safe exposure threshold. Countries that have implemented comprehensive asbestos bans show early evidence of declining mesothelioma rates in younger cohorts, demonstrating that regulatory action reduces the disease burden over time. For people with a history of asbestos exposure, awareness of symptoms such as persistent shortness of breath, chest pain, or unexplained abdominal swelling is important given the long latency of mesothelioma. Formal population screening programs for mesothelioma are not yet standard practice, though research into surveillance strategies for high-risk groups continues.